Table 1. Demographic and baseline clinical characteristics of all stroke patients involved in our study.
| Non-SAI | SAI | P | |
|---|---|---|---|
| Demographic characteristics | |||
| Total, n | 42 | 26 | |
| Age, mean (SEM), y | 70 (61–81) | 80 (66–85) | 0.032 |
| Female, n (%) | 16 (38.10) | 8 (30.77) | 0.539 |
| Vascular risk factors, n (%) | |||
| Hypertension | 35 (83.33) | 16 (61.54) | 0.440 |
| Smoking history | 10 (23.81) | 5 (19.23) | 0.658 |
| Atrial Fibrillation | 6 (14.29) | 7 (26.92) | 0.220 |
| Diabetes mellitus | 17 (40.48) | 7 (26.92) | 0.256 |
| Previous TIA/stroke/MI | 5 (11.90) | 6 (23.08) | 0.312 |
| Laboratory parameters, mean (SEM) | |||
| Glucose (mmol/l) | 6.24 (5.50–8.77) | 6.81 (5.82–10.10) | 0.358 |
| Triglycerides (mmol/l) | 1.19 (0.88–1.68) | 0.96 (0.67–1.20) | 0.014 |
| Total cholesterol (mmol/l) | 4.32 (3.76–5.22) | 4.75 (3.45-5.09) | 0.950 |
| HDL (mmol/l) | 1.18 (0.94–1.25) | 1.14 (0.97–1.42) | 0.925 |
| LDL (mmol/l) | 2.63 (0.13) | 2.64 (0.19) | 0.982 |
| Lpa (g/l) | 154 (81–456) | 220 (94–384) | 0.900 |
| WBC (109/l) | 7.22 (0.37) | 8.75 (0.57) | 0.018 |
| RBC (1012/l) | 4.78 (0.13) | 4.43 (0.16) | 0.074 |
| Neutrophils ratio (%) | 67.75 (57.33–75.08) | 79.8 (66.88–83.14) | 0.012 |
| Hemoglobin (g/l) | 143.41 (3.25) | 135.58 (4.52) | 0.137 |
| Platelets (109/l) | 200.41 (9.81) | 199.42 (10.31) | 0.954 |
| BUN (mmol/l) | 5.0 (4.2–6.5) | 6.3 (4.7–7.1) | 0.077 |
| Creatinine (μmol/l) | 76.46 (3.35) | 82.27 (5.82) | 0.330 |
| Total Protein (g/l) | 64.52 (0.78) | 64.46 (1.43) | 0.995 |
| Albumin (g/l) | 38.7 (34.8–40.4) | 38.0 (34.7–40.5) | 0.460 |
| Medication, n (%) | |||
| ARBs | 6 (14.29) | 1 (3.85) | 0.238 |
| ACEIs | 9 (21.42) | 1 (3.85) | 0.076 |
| β-Blocker | 7 (16.67) | 1 (3.85) | 0.142 |
| CCBs | 14 (33.33) | 10 (38.46) | 0.667 |
| Diuretics | 8 (19.05) | 2 (7.69) | 0.297 |
| NIHSS | 8 (6–11) | 11 (7–16) | 0.012 |
Abbreviations: ACE I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BUN, blood urea nitrogen; CCB, calcium channel blocker; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LPa, apolipoprotein A; MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; RBC, red blood cell; SAI, stroke associated infection; TIA, transient ischemic attack; WBC, white blood cell.